BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Applied Medical Visualizations LLC (Medvis) Announces a Patent License Agreement With GE Healthcare

  August 21, 2012

   · 

  1 min read
• Drug Development

  Ocular Therapeutix, Inc. Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma

  August 21, 2012

   · 

  3 min read
• Business

  Electromed, Inc. Announces Hiring of Director of Sales

  August 21, 2012

   · 

  1 min read
• Systagenix Launches New Wound Care Products in Brazil

  August 21, 2012

   · 

  1 min read
• Biotech Bay

  ZELTIQ® Aesthetics Introduces Crystal Rewards Program

  August 21, 2012

   · 

  1 min read
• Biotech Bay

  Fluidigm Corporation Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $60 million Public Offering of Common Stock

  August 21, 2012

   · 

  1 min read
• Bio NC

  Inc. Magazine Names Clinipace Inc. Worldwide to Its 2012 Inc. 500 List for Third Consecutive Year

  August 21, 2012

   · 

  1 min read
• Business

  Electromed, Inc. Announces Hiring of Director of Marketing

  August 21, 2012

   · 

  1 min read
• Bio NC

  Laboratory Corporation of America Holdings (LabCorp) Prices $500 Million in 2.20% Senior Notes Due 2017 and $500 Million in 3.75% Senior Notes Due 2022

  August 21, 2012

   · 

  1 min read
• Drug Development

  PhaseBio Pharmaceuticals, Inc. Initiates a Multicenter, Randomized Placebo and Active Comparator Controlled Phase 2b Trial to Evaluate Use of Glymera for the Treatment of Uncontrolled Type 2 Diabetes

  August 21, 2012

   · 

  1 min read